286 related articles for article (PubMed ID: 20889201)
1. The promotion of myocardial repair by the sequential delivery of IGF-1 and HGF from an injectable alginate biomaterial in a model of acute myocardial infarction.
Ruvinov E; Leor J; Cohen S
Biomaterials; 2011 Jan; 32(2):565-78. PubMed ID: 20889201
[TBL] [Abstract][Full Text] [Related]
2. The effects of controlled HGF delivery from an affinity-binding alginate biomaterial on angiogenesis and blood perfusion in a hindlimb ischemia model.
Ruvinov E; Leor J; Cohen S
Biomaterials; 2010 Jun; 31(16):4573-82. PubMed ID: 20206988
[TBL] [Abstract][Full Text] [Related]
3. Delivery of alginate-chitosan hydrogel promotes endogenous repair and preserves cardiac function in rats with myocardial infarction.
Deng B; Shen L; Wu Y; Shen Y; Ding X; Lu S; Jia J; Qian J; Ge J
J Biomed Mater Res A; 2015 Mar; 103(3):907-18. PubMed ID: 24827141
[TBL] [Abstract][Full Text] [Related]
4. Complementary therapeutic effects of dual delivery of insulin-like growth factor-1 and vascular endothelial growth factor by gelatin microspheres in experimental heart failure.
Cittadini A; Monti MG; Petrillo V; Esposito G; Imparato G; Luciani A; Urciuolo F; Bobbio E; Natale CF; Saccà L; Netti PA
Eur J Heart Fail; 2011 Dec; 13(12):1264-74. PubMed ID: 22045926
[TBL] [Abstract][Full Text] [Related]
5. Effect of injectable alginate implant on cardiac remodeling and function after recent and old infarcts in rat.
Landa N; Miller L; Feinberg MS; Holbova R; Shachar M; Freeman I; Cohen S; Leor J
Circulation; 2008 Mar; 117(11):1388-96. PubMed ID: 18316487
[TBL] [Abstract][Full Text] [Related]
6. Intracoronary injection of in situ forming alginate hydrogel reverses left ventricular remodeling after myocardial infarction in Swine.
Leor J; Tuvia S; Guetta V; Manczur F; Castel D; Willenz U; Petneházy O; Landa N; Feinberg MS; Konen E; Goitein O; Tsur-Gang O; Shaul M; Klapper L; Cohen S
J Am Coll Cardiol; 2009 Sep; 54(11):1014-23. PubMed ID: 19729119
[TBL] [Abstract][Full Text] [Related]
7. Hepatocyte growth factor or vascular endothelial growth factor gene transfer maximizes mesenchymal stem cell-based myocardial salvage after acute myocardial infarction.
Deuse T; Peter C; Fedak PW; Doyle T; Reichenspurner H; Zimmermann WH; Eschenhagen T; Stein W; Wu JC; Robbins RC; Schrepfer S
Circulation; 2009 Sep; 120(11 Suppl):S247-54. PubMed ID: 19752375
[TBL] [Abstract][Full Text] [Related]
8. Induction of angiogenesis and inhibition of apoptosis by hepatocyte growth factor effectively treats postischemic heart failure.
Jayasankar V; Woo YJ; Pirolli TJ; Bish LT; Berry MF; Burdick J; Gardner TJ; Sweeney HL
J Card Surg; 2005; 20(1):93-101. PubMed ID: 15673421
[TBL] [Abstract][Full Text] [Related]
9. Angiogenesis induced by hepatocyte growth factor in non-infarcted myocardium and infarcted myocardium: up-regulation of essential transcription factor for angiogenesis, ets.
Aoki M; Morishita R; Taniyama Y; Kida I; Moriguchi A; Matsumoto K; Nakamura T; Kaneda Y; Higaki J; Ogihara T
Gene Ther; 2000 Mar; 7(5):417-27. PubMed ID: 10694824
[TBL] [Abstract][Full Text] [Related]
10. Early treatment with hepatocyte growth factor improves cardiac function in experimental heart failure induced by myocardial infarction.
Jin H; Yang R; Li W; Ogasawara AK; Schwall R; Eberhard DA; Zheng Z; Kahn D; Paoni NF
J Pharmacol Exp Ther; 2003 Feb; 304(2):654-60. PubMed ID: 12538818
[TBL] [Abstract][Full Text] [Related]
11. Treatment of acute myocardial infarction by hepatocyte growth factor gene transfer: the first demonstration of myocardial transfer of a "functional" gene using ultrasonic microbubble destruction.
Kondo I; Ohmori K; Oshita A; Takeuchi H; Fuke S; Shinomiya K; Noma T; Namba T; Kohno M
J Am Coll Cardiol; 2004 Aug; 44(3):644-53. PubMed ID: 15358035
[TBL] [Abstract][Full Text] [Related]
12. Addition of hyaluronic acid to alginate embedded chondrocytes interferes with insulin-like growth factor-1 signaling in vitro and in vivo.
Yoon DM; Curtiss S; Reddi AH; Fisher JP
Tissue Eng Part A; 2009 Nov; 15(11):3449-59. PubMed ID: 19426107
[TBL] [Abstract][Full Text] [Related]
13. Functionalized nanoparticles provide early cardioprotection after acute myocardial infarction.
Chang MY; Yang YJ; Chang CH; Tang AC; Liao WY; Cheng FY; Yeh CS; Lai JJ; Stayton PS; Hsieh PC
J Control Release; 2013 Sep; 170(2):287-94. PubMed ID: 23665256
[TBL] [Abstract][Full Text] [Related]
14. Potent long-term cardioprotective effects of single low-dose insulin-like growth factor-1 treatment postmyocardial infarction.
O'Sullivan JF; Leblond AL; Kelly G; Kumar AH; Metharom P; Büneker CK; Alizadeh-Vikali N; Hristova I; Hynes BG; O'Connor R; Caplice NM
Circ Cardiovasc Interv; 2011 Aug; 4(4):327-35. PubMed ID: 21712526
[TBL] [Abstract][Full Text] [Related]
15. Intra-myocardial injection of both growth factors and heart derived Sca-1+/CD31- cells attenuates post-MI LV remodeling more than does cell transplantation alone: neither intervention enhances functionally significant cardiomyocyte regeneration.
Wang X; Li Q; Hu Q; Suntharalingam P; From AH; Zhang J
PLoS One; 2014; 9(2):e95247. PubMed ID: 24919180
[TBL] [Abstract][Full Text] [Related]
16. An injectable capillary-like microstructured alginate hydrogel improves left ventricular function after myocardial infarction in rats.
Rocca DG; Willenberg BJ; Qi Y; Simmons CS; Rubiano A; Ferreira LF; Huo T; Petersen JW; Ruchaya PJ; Wate PS; Wise EA; Handberg EM; Cogle CR; Batich CD; Byrne BJ; Pepine CJ
Int J Cardiol; 2016 Oct; 220():149-54. PubMed ID: 27379917
[TBL] [Abstract][Full Text] [Related]
17. Hepatocyte growth factor and granulocyte colony-stimulating factor form a combined neovasculogenic therapy for ischemic cardiomyopathy.
Guo YH; He JG; Wu JL; Yang L; Zhang DS; Tan XY; Qi RD
Cytotherapy; 2008; 10(8):857-67. PubMed ID: 18956268
[TBL] [Abstract][Full Text] [Related]
18. Experimental study of bone marrow-derived mesenchymal stem cells combined with hepatocyte growth factor transplantation via noninfarct-relative artery in acute myocardial infarction.
Yang ZJ; Ma DC; Wang W; Xu SL; Zhang YQ; Chen B; Zhou F; Zhu TB; Wang LS; Xu ZQ; Zhang FM; Cao KJ; Ma WZ
Gene Ther; 2006 Nov; 13(22):1564-8. PubMed ID: 16810195
[TBL] [Abstract][Full Text] [Related]
19. Monocyte derivatives promote angiogenesis and myocyte survival in a model of myocardial infarction.
Bouchentouf M; Paradis P; Forner KA; Cuerquis J; Boivin MN; Zheng J; Boulassel MR; Routy JP; Schiffrin EL; Galipeau J
Cell Transplant; 2010; 19(4):369-86. PubMed ID: 20021736
[TBL] [Abstract][Full Text] [Related]
20. Endogenous cardiac stem cell activation by insulin-like growth factor-1/hepatocyte growth factor intracoronary injection fosters survival and regeneration of the infarcted pig heart.
Ellison GM; Torella D; Dellegrottaglie S; Perez-Martinez C; Perez de Prado A; Vicinanza C; Purushothaman S; Galuppo V; Iaconetti C; Waring CD; Smith A; Torella M; Cuellas Ramon C; Gonzalo-Orden JM; Agosti V; Indolfi C; Galiñanes M; Fernandez-Vazquez F; Nadal-Ginard B
J Am Coll Cardiol; 2011 Aug; 58(9):977-86. PubMed ID: 21723061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
